Development of Ligand-Drug Conjugates Targeting Melanoma through the Overexpressed Melanocortin 1 Receptor.
Saved in:
| Title: | Development of Ligand-Drug Conjugates Targeting Melanoma through the Overexpressed Melanocortin 1 Receptor. |
|---|---|
| Authors: | Zhou Y; Department of Chemistry and Biochemistry, The University of Arizona, Tucson, Arizona 85721, United States., Mowlazadeh Haghighi S; Department of Chemistry and Biochemistry, The University of Arizona, Tucson, Arizona 85721, United States., Liu Z; Department of Chemistry and Biochemistry, The University of Arizona, Tucson, Arizona 85721, United States., Wang L; Department of Chemistry and Biochemistry, The University of Arizona, Tucson, Arizona 85721, United States., Hruby VJ; Department of Chemistry and Biochemistry, The University of Arizona, Tucson, Arizona 85721, United States., Cai M; Department of Chemistry and Biochemistry, The University of Arizona, Tucson, Arizona 85721, United States. |
| Source: | ACS pharmacology & translational science [ACS Pharmacol Transl Sci] 2020 Aug 18; Vol. 3 (5), pp. 921-930. Date of Electronic Publication: 2020 Aug 18 (Print Publication: 2020). |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: American Chemical Society Country of Publication: United States NLM ID: 101721411 Publication Model: eCollection Cited Medium: Internet ISSN: 2575-9108 (Electronic) Linking ISSN: 25759108 NLM ISO Abbreviation: ACS Pharmacol Transl Sci Subsets: PubMed not MEDLINE |
| Database: | MEDLINE Ultimate |
Be the first to leave a comment!
